Revuforj (Revumenib)

Revuforj (revumenib) is a menin inhibitor used for the treatment of relapsed or refractory acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation in adult and pediatric patients aged 1 year and older.

Recommended Dosage: The recommended dosage of Revumenib depends on the patient’s body weight and also the use of potent CYP3A4 inhibitors. In patients equaling or exceeding the weight of 40 kg, the dose is 270 mg taken orally two times every day for those without strong CYP3A4 inhibitors and 160 mg taken orally two times every day for those with strong CYP3A4 inhibitors. For patients under 40 kg, the dosing is 160 mg/m² taken orally two times every day for those without strong CYP3A4 inhibitors and 95 mg/m² taken orally 2 times every day for those with strong CYP3A4 inhibitors. This applies to all patients over 1 year of age and older. Every patient must talk with their healthcare provider (HCP) for appropriate dosing.

• Revumenib has been reported to result in potentially life-threatening differentiation syndrome. This syndrome is manifested by fever, weight gain, and breathing problems. If you experience any of the above-described symptoms, see your physician immediately for further management and follow-up.
• This therapy has the possibility of prolonging the ‘QTc’ interval of an electrocardiogram, which can affect the heart's rhythm. Your heart will need to be checked on a regular basis. Do not use this medication along with those that prolong the QTc. Be sure to tell your doctor whether your heart has been weak for a long time.
• The use of Revumenib 25 mg/110 mg/160 mg is not safe during pregnancy as it can result in damage to the fetus. These tablets should be avoided during pregnancy. Women who require this medicine should use contraceptive methods and inform their doctor if they become pregnant.
• It is not advisable to breastfeed a child while Revumenib treatment is underway. The medication may enter breast milk and adversely affect the infant. Speak to your physician for other feeding alternatives.

What documents are required to import REVUFORJ to India?

REVUFORJ (revumenib) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
A valid prescription from a qualified doctor.
Patients diagnostic reports
Patient ID proof (issued by the government of India)

How does the order be confirmed?
The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is REVUFORJ available in India?

REVUFORJ (revumenib tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Revuforj in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada,
• Europe, and Australia
• Ensuring 100% transparency.

REVUFORJ can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of REVUFORJ (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Revuforj 25 mg/110 mg/160 mg price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source REVUFORJ (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Revuforj®?

Revumenib is a Generic Name for the trade name drug Revuforj®.

What is the Manufacturer's Name of Revuforj®?
Revuforj® is manufactured by Neurocrine Biosciences, Inc.

Is Revuforj® approved by the FDA?

Yes, Revuforj® is approved by the FDA. Date of first approval: November 15, 2024.

What is the dosage and form of Revuforj® supplied?

Revuforj is supplied in Tablets: of 25 mg, 110 mg, and 160 mg for oral administration.

What are the most common side effects of Revuforj® 25 mg/110 mg/160 mg Tablets?

The most common side effects of Revuforj® in adults are hemorrhage, nausea, musculoskeletal pain, infection, bacterial infection, QTc interval prolongation, febrile neutropenia, constipation, decreased appetite, edema, viral infection, differentiation syndrome, diarrhea, and fatigue.

How much does Revuforj® 25 mg/110 mg/160 mg Tablets cost in India?

Prices of Revuforj 25 mg/110 mg/160 mg tablets may fluctuate over time because of market dynamics and regulatory changes. To get the most transparent Revuforj 25 mg/110 mg/160 mg cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Revuforj® 25 mg/110 mg/160 mg Tablets be available in SAARC countries?

Apart from Gulf countries, Revuforj® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Revuforj® Tablets in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Revuforj® 25 mg/110 mg/160 mg Tablets online in India?

Yes, one can buy Revuforj 25 mg/110 mg/160 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Revuforj® oral tablets through legal channels.

What are the storage conditions of Revuforj® 25 mg/110 mg/160 mg Tablets?
Store tablets at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). Keep the oral tablets in the original container until dispensed.